Cargando…
The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma
BACKGROUND: Inhibition of Serum Amyloid A-like 1 (SAAL1) expression could inhibit cancer progression and improve the prognosis of cancer patients. At present, the correlation between SAAL1 and lung adenocarcinoma (LAC) remains unclear. Therefore, this study surveyed the worth and pathway of SAAL1 in...
Autores principales: | Tong, Song, Jiang, Ni, Wan, Jun-Hao, Chen, Chong-Rui, Wang, Si-Hua, Wu, Chuang-Yan, Guo, Qiang, Xiao, Xiao-Yue, Huang, Huan, Zhou, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041717/ https://www.ncbi.nlm.nih.gov/pubmed/36973678 http://dx.doi.org/10.1186/s12885-023-10741-5 |
Ejemplares similares
-
Bisphenol A: vom Saal and Hughes Respond
por: vom Saal, Frederick S., et al.
Publicado: (2006) -
Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma
por: Chu, Pei-Yi, et al.
Publicado: (2020) -
SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
por: Yang, Wei, et al.
Publicado: (2022) -
A Novel lncRNA SAAL Suppresses IAV Replication by Promoting Innate Responses
por: Liu, Qingzheng, et al.
Publicado: (2022) -
The silencing of SAAL1 suppresses pneumonia progression via modulating the NLR signaling pathway
por: Chen, Wei, et al.
Publicado: (2022)